| Sanford Wheaton Medical Center | |
| 401 12th Street North, Wheaton, Minnesota 56296 | |
| (320) 563-8226 | |
| Not Available |
| Name | Sanford Wheaton Medical Center |
|---|---|
| Type | Critical Access Hospital |
| Location | 401 12th Street North, Wheaton, Minnesota |
| Ownership | Voluntary non-profit - Private |
| Emergency Services | Yes |
| Medicare ID (CCN) | 241304 |
| NPI Number | 1154615573 |
| Organization Name | SANFORD HEALTH NETWORK NORTH |
| Doing Business As | SANFORD WHEATON-AMBULANCE |
| Address | 401 12th St N, Wheaton, MN 56296 |
| Hospital Type | General Acute Care Hospital - Critical Access |
| Phone Number | 320-563-8971 |
News Archive
Building on his Nobel Prize-winning work creating fluorescent proteins that light up the inner workings of cells, a team of researchers led by Howard Hughes Medical Institute investigator Roger Tsien, PhD, professor of pharmacology, chemistry and biochemistry at the University of California, San Diego and the Moores UCSD Cancer Center has developed biological probes that can stick to and light up tumors in mice.
Today, the National Comprehensive Cancer Network published new NCCN Clinical Practice Guidelines in Oncology for Hematopoietic Cell Transplantation, also known as stem cell transplant or historically as bone marrow transplant.
ImmunoCellular Therapeutics, Ltd., a biotechnology company focused on the development of novel immune-based cancer therapies, today announced the expansion of sites for its Phase II clinical trial of ICT-107. ICT-107 is the Company's dendritic cell based cancer vaccine candidate targeting multiple tumor antigens for the treatment of glioblastoma multiforme (GBM).
They outlined their concerns in a letter sent this week to Health and Human Services Secretary Kathleen Sebelius. Meanwhile, Marilyn Tavenner, the Centers for Medicare and Medicaid Services acting administrator, provided details about the innovation center's staffing and funding to Sen. Orrin Hatch, R-Utah.
› Verified 8 days ago
| NPI Number | 1326045253 |
| Organization Name | CITY OF WHEATON |
| Doing Business As | WHEATON COMMUNITY HOSPITAL |
| Address | 401 12th St N, Wheaton, MN 56296 |
| Hospital Type | General Acute Care Hospital - Critical Access |
| Phone Number | 320-563-8226 |
News Archive
Building on his Nobel Prize-winning work creating fluorescent proteins that light up the inner workings of cells, a team of researchers led by Howard Hughes Medical Institute investigator Roger Tsien, PhD, professor of pharmacology, chemistry and biochemistry at the University of California, San Diego and the Moores UCSD Cancer Center has developed biological probes that can stick to and light up tumors in mice.
Today, the National Comprehensive Cancer Network published new NCCN Clinical Practice Guidelines in Oncology for Hematopoietic Cell Transplantation, also known as stem cell transplant or historically as bone marrow transplant.
ImmunoCellular Therapeutics, Ltd., a biotechnology company focused on the development of novel immune-based cancer therapies, today announced the expansion of sites for its Phase II clinical trial of ICT-107. ICT-107 is the Company's dendritic cell based cancer vaccine candidate targeting multiple tumor antigens for the treatment of glioblastoma multiforme (GBM).
They outlined their concerns in a letter sent this week to Health and Human Services Secretary Kathleen Sebelius. Meanwhile, Marilyn Tavenner, the Centers for Medicare and Medicaid Services acting administrator, provided details about the innovation center's staffing and funding to Sen. Orrin Hatch, R-Utah.
› Verified 8 days ago
| Able to receive lab results electronically | Not Available |
| Able to track patients' lab results, tests, and referrals electronically between visits | Not Available |
News Archive
Building on his Nobel Prize-winning work creating fluorescent proteins that light up the inner workings of cells, a team of researchers led by Howard Hughes Medical Institute investigator Roger Tsien, PhD, professor of pharmacology, chemistry and biochemistry at the University of California, San Diego and the Moores UCSD Cancer Center has developed biological probes that can stick to and light up tumors in mice.
Today, the National Comprehensive Cancer Network published new NCCN Clinical Practice Guidelines in Oncology for Hematopoietic Cell Transplantation, also known as stem cell transplant or historically as bone marrow transplant.
ImmunoCellular Therapeutics, Ltd., a biotechnology company focused on the development of novel immune-based cancer therapies, today announced the expansion of sites for its Phase II clinical trial of ICT-107. ICT-107 is the Company's dendritic cell based cancer vaccine candidate targeting multiple tumor antigens for the treatment of glioblastoma multiforme (GBM).
They outlined their concerns in a letter sent this week to Health and Human Services Secretary Kathleen Sebelius. Meanwhile, Marilyn Tavenner, the Centers for Medicare and Medicaid Services acting administrator, provided details about the innovation center's staffing and funding to Sen. Orrin Hatch, R-Utah.
› Verified 8 days ago
Sanford Wheaton Medical Center Critical Access Hospital Location: 401 12th Street North, Wheaton, Minnesota 56296 Phone: (320) 563-8226 |